Covid-19 Impact on Gadobutrol (CAS 138071-82-6) Market, Global Research Reports 2020-2021
This report covers market size and forecasts of Gadobutrol (CAS 138071-82-6), including the following market information:
Major competitors identified in this market include Bayer HealthCare Pharmaceuticals Inc., SWAPNROOP DRUGS & PHARMACEUTICALS, Manus Aktteva Biopharma LLP, Jilin Tely Imp & Exp CO.,LTD, JinYan Chemicals (ShangHai) Co., Ltd., BOC Sciences, LGM Pharma, Advanced Technology & Industrail Co., Ltd., MedKoo Biosciences, Inc., etc.
Based on the Region:
- Global Gadobutrol (CAS 138071-82-6) Market Size, 2019-2021, and 2020 (quarterly data), (US$ Million) & (K MT)
- Global Gadobutrol (CAS 138071-82-6) Market Size by Type and by Application, 2019-2021, and 2020 (quarterly data), (US$ Million) & (K MT)
- Global Gadobutrol (CAS 138071-82-6) Market Size by Region (and Key Countries), 2019-2021, and 2020 (quarterly data), (US$ Million) & (K MT)
- Global Gadobutrol (CAS 138071-82-6) Market Size by Company, 2019- 2020 (quarterly data), (US$ Million) & (K MT)
Major competitors identified in this market include Bayer HealthCare Pharmaceuticals Inc., SWAPNROOP DRUGS & PHARMACEUTICALS, Manus Aktteva Biopharma LLP, Jilin Tely Imp & Exp CO.,LTD, JinYan Chemicals (ShangHai) Co., Ltd., BOC Sciences, LGM Pharma, Advanced Technology & Industrail Co., Ltd., MedKoo Biosciences, Inc., etc.
Based on the Region:
- Asia-Pacific (China, Japan, South Korea, India and ASEAN)
- North America (US and Canada)
- Europe (Germany, France, UK and Italy)
- Rest of World (Latin America, Middle East & Africa)
- Single Dose Vials (2 mL, 7.5 mL, 10mL, and 15 mL)
- Single Dose Pre-filled Injections (7.5 mL, 10 mL, 15 mL)
- Pharmacy Bulk Packages (30 mL and 65 mL)
- Adults
- Children
1.1 Research Scope
1.2 Market Segmentation
1.3 Research Objectives
1.4 Research Methodology
1.4.1 Research Process
1.4.2 Data Triangulation
1.4.3 Research Approach
1.4.4 Base Year
1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.5.2 Covid-19 Impact: Commodity Prices Indices
1.5.3 Covid-19 Impact: Global Major Government Policy
1.6 The Covid-19 Impact on Gadobutrol (CAS 138071-82-6) Industry
1.7 COVID-19 Impact: Gadobutrol (CAS 138071-82-6) Market Trends
2 GLOBAL GADOBUTROL (CAS 138071-82-6) QUARTERLY MARKET SIZE ANALYSIS
2.1 Gadobutrol (CAS 138071-82-6) Business Impact Assessment - COVID-19
2.1.1 Global Gadobutrol (CAS 138071-82-6) Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
2.1.2 Global Gadobutrol (CAS 138071-82-6) Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
2.2 Global Gadobutrol (CAS 138071-82-6) Quarterly Market Size 2020-2021
2.3 COVID-19-Driven Market Dynamics and Factor Analysis
2.3.1 Drivers
2.3.2 Restraints
2.3.3 Opportunities
2.3.4 Challenges
3 QUARTERLY COMPETITIVE ASSESSMENT, 2020
3.1 Global Gadobutrol (CAS 138071-82-6) Quarterly Market Size by Manufacturers, 2019 VS 2020
3.2 Global Gadobutrol (CAS 138071-82-6) Factory Price by Manufacturers
3.3 Location of Key Manufacturers Gadobutrol (CAS 138071-82-6) Manufacturing Factories and Area Served
3.4 Date of Key Manufacturers Enter into Gadobutrol (CAS 138071-82-6) Market
3.5 Key Manufacturers Gadobutrol (CAS 138071-82-6) Product Offered
3.6 Mergers & Acquisitions, Expansion Plans
4 IMPACT OF COVID-19 ON GADOBUTROL (CAS 138071-82-6) SEGMENTS, BY TYPE
4.1 Introduction
1.4.1 Single Dose Vials (2 mL, 7.5 mL, 10mL, and 15 mL)
1.4.2 Single Dose Pre-filled Injections (7.5 mL, 10 mL, 15 mL)
1.4.3 Pharmacy Bulk Packages (30 mL and 65 mL)
4.2 By Type, Global Gadobutrol (CAS 138071-82-6) Market Size, 2019-2021
4.2.1 By Type, Global Gadobutrol (CAS 138071-82-6) Market Size by Type, 2020-2021
4.2.2 By Type, Global Gadobutrol (CAS 138071-82-6) Price, 2020-2021
5 IMPACT OF COVID-19 ON GADOBUTROL (CAS 138071-82-6) SEGMENTS, BY APPLICATION
5.1 Overview
5.5.1 Adults
5.5.2 Children
5.2 By Application, Global Gadobutrol (CAS 138071-82-6) Market Size, 2019-2021
5.2.1 By Application, Global Gadobutrol (CAS 138071-82-6) Market Size by Application, 2019-2021
5.2.2 By Application, Global Gadobutrol (CAS 138071-82-6) Price, 2020-2021
6 GEOGRAPHIC ANALYSIS
6.1 Introduction
6.2 North America
6.2.1 Macroeconomic Indicators of US
6.2.2 US
6.2.3 Canada
6.3 Europe
6.3.1 Macroeconomic Indicators of Europe
6.3.2 Germany
6.3.3 France
6.3.4 UK
6.3.5 Italy
6.4 Asia-Pacific
6.4.1 Macroeconomic Indicators of Asia-Pacific
6.4.2 China
6.4.3 Japan
6.4.4 South Korea
6.4.5 India
6.4.6 ASEAN
6.5 Rest of World
6.5.1 Latin America
6.5.2 Middle East and Africa
7 COMPANY PROFILES
7.1 Bayer HealthCare Pharmaceuticals Inc.
7.1.1 Bayer HealthCare Pharmaceuticals Inc. Business Overview
7.1.2 Bayer HealthCare Pharmaceuticals Inc. Gadobutrol (CAS 138071-82-6) Quarterly Production and Revenue, 2020
7.1.3 Bayer HealthCare Pharmaceuticals Inc. Gadobutrol (CAS 138071-82-6) Product Introduction
7.1.4 Bayer HealthCare Pharmaceuticals Inc. Response to COVID-19 and Related Developments
7.2 SWAPNROOP DRUGS & PHARMACEUTICALS
7.2.1 SWAPNROOP DRUGS & PHARMACEUTICALS Business Overview
7.2.2 SWAPNROOP DRUGS & PHARMACEUTICALS Gadobutrol (CAS 138071-82-6) Quarterly Production and Revenue, 2020
7.2.3 SWAPNROOP DRUGS & PHARMACEUTICALS Gadobutrol (CAS 138071-82-6) Product Introduction
7.2.4 SWAPNROOP DRUGS & PHARMACEUTICALS Response to COVID-19 and Related Developments
7.3 Manus Aktteva Biopharma LLP
7.3.1 Manus Aktteva Biopharma LLP Business Overview
7.3.2 Manus Aktteva Biopharma LLP Gadobutrol (CAS 138071-82-6) Quarterly Production and Revenue, 2020
7.3.3 Manus Aktteva Biopharma LLP Gadobutrol (CAS 138071-82-6) Product Introduction
7.3.4 Manus Aktteva Biopharma LLP Response to COVID-19 and Related Developments
7.4 Jilin Tely Imp & Exp CO.,LTD
7.4.1 Jilin Tely Imp & Exp CO.,LTD Business Overview
7.4.2 Jilin Tely Imp & Exp CO.,LTD Gadobutrol (CAS 138071-82-6) Quarterly Production and Revenue, 2020
7.4.3 Jilin Tely Imp & Exp CO.,LTD Gadobutrol (CAS 138071-82-6) Product Introduction
7.4.4 Jilin Tely Imp & Exp CO.,LTD Response to COVID-19 and Related Developments
7.5 JinYan Chemicals (ShangHai) Co., Ltd.
7.5.1 JinYan Chemicals (ShangHai) Co., Ltd. Business Overview
7.5.2 JinYan Chemicals (ShangHai) Co., Ltd. Gadobutrol (CAS 138071-82-6) Quarterly Production and Revenue, 2020
7.5.3 JinYan Chemicals (ShangHai) Co., Ltd. Gadobutrol (CAS 138071-82-6) Product Introduction
7.5.4 JinYan Chemicals (ShangHai) Co., Ltd. Response to COVID-19 and Related Developments
7.6 BOC Sciences
7.6.1 BOC Sciences Business Overview
7.6.2 BOC Sciences Gadobutrol (CAS 138071-82-6) Quarterly Production and Revenue, 2020
7.6.3 BOC Sciences Gadobutrol (CAS 138071-82-6) Product Introduction
7.6.4 BOC Sciences Response to COVID-19 and Related Developments
7.7 LGM Pharma
7.7.1 LGM Pharma Business Overview
7.7.2 LGM Pharma Gadobutrol (CAS 138071-82-6) Quarterly Production and Revenue, 2020
7.7.3 LGM Pharma Gadobutrol (CAS 138071-82-6) Product Introduction
7.7.4 LGM Pharma Response to COVID-19 and Related Developments
7.8 Advanced Technology & Industrail Co., Ltd.
7.8.1 Advanced Technology & Industrail Co., Ltd. Business Overview
7.8.2 Advanced Technology & Industrail Co., Ltd. Gadobutrol (CAS 138071-82-6) Quarterly Production and Revenue, 2020
7.8.3 Advanced Technology & Industrail Co., Ltd. Gadobutrol (CAS 138071-82-6) Product Introduction
7.8.4 Advanced Technology & Industrail Co., Ltd. Response to COVID-19 and Related Developments
7.9 MedKoo Biosciences, Inc.
7.9.1 MedKoo Biosciences, Inc. Business Overview
7.9.2 MedKoo Biosciences, Inc. Gadobutrol (CAS 138071-82-6) Quarterly Production and Revenue, 2020
7.9.3 MedKoo Biosciences, Inc. Gadobutrol (CAS 138071-82-6) Product Introduction
7.9.4 MedKoo Biosciences, Inc. Response to COVID-19 and Related Developments
8 SUPPLY CHAIN AND SALES CHANNELS ANALYSIS
8.1 Gadobutrol (CAS 138071-82-6) Supply Chain Analysis
8.1.1 Gadobutrol (CAS 138071-82-6) Supply Chain Analysis
8.1.2 Covid-19 Impact on Gadobutrol (CAS 138071-82-6) Supply Chain
8.2 Distribution Channels Analysis
8.2.1 Gadobutrol (CAS 138071-82-6) Distribution Channels
8.2.2 Covid-19 Impact on Gadobutrol (CAS 138071-82-6) Distribution Channels
8.2.3 Gadobutrol (CAS 138071-82-6) Distributors
8.3 Gadobutrol (CAS 138071-82-6) Customers
9 KEY FINDINGS
10 APPENDIX
10.1 About Us
10.2 Disclaimer
1.2 Market Segmentation
1.3 Research Objectives
1.4 Research Methodology
1.4.1 Research Process
1.4.2 Data Triangulation
1.4.3 Research Approach
1.4.4 Base Year
1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.5.2 Covid-19 Impact: Commodity Prices Indices
1.5.3 Covid-19 Impact: Global Major Government Policy
1.6 The Covid-19 Impact on Gadobutrol (CAS 138071-82-6) Industry
1.7 COVID-19 Impact: Gadobutrol (CAS 138071-82-6) Market Trends
2 GLOBAL GADOBUTROL (CAS 138071-82-6) QUARTERLY MARKET SIZE ANALYSIS
2.1 Gadobutrol (CAS 138071-82-6) Business Impact Assessment - COVID-19
2.1.1 Global Gadobutrol (CAS 138071-82-6) Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
2.1.2 Global Gadobutrol (CAS 138071-82-6) Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
2.2 Global Gadobutrol (CAS 138071-82-6) Quarterly Market Size 2020-2021
2.3 COVID-19-Driven Market Dynamics and Factor Analysis
2.3.1 Drivers
2.3.2 Restraints
2.3.3 Opportunities
2.3.4 Challenges
3 QUARTERLY COMPETITIVE ASSESSMENT, 2020
3.1 Global Gadobutrol (CAS 138071-82-6) Quarterly Market Size by Manufacturers, 2019 VS 2020
3.2 Global Gadobutrol (CAS 138071-82-6) Factory Price by Manufacturers
3.3 Location of Key Manufacturers Gadobutrol (CAS 138071-82-6) Manufacturing Factories and Area Served
3.4 Date of Key Manufacturers Enter into Gadobutrol (CAS 138071-82-6) Market
3.5 Key Manufacturers Gadobutrol (CAS 138071-82-6) Product Offered
3.6 Mergers & Acquisitions, Expansion Plans
4 IMPACT OF COVID-19 ON GADOBUTROL (CAS 138071-82-6) SEGMENTS, BY TYPE
4.1 Introduction
1.4.1 Single Dose Vials (2 mL, 7.5 mL, 10mL, and 15 mL)
1.4.2 Single Dose Pre-filled Injections (7.5 mL, 10 mL, 15 mL)
1.4.3 Pharmacy Bulk Packages (30 mL and 65 mL)
4.2 By Type, Global Gadobutrol (CAS 138071-82-6) Market Size, 2019-2021
4.2.1 By Type, Global Gadobutrol (CAS 138071-82-6) Market Size by Type, 2020-2021
4.2.2 By Type, Global Gadobutrol (CAS 138071-82-6) Price, 2020-2021
5 IMPACT OF COVID-19 ON GADOBUTROL (CAS 138071-82-6) SEGMENTS, BY APPLICATION
5.1 Overview
5.5.1 Adults
5.5.2 Children
5.2 By Application, Global Gadobutrol (CAS 138071-82-6) Market Size, 2019-2021
5.2.1 By Application, Global Gadobutrol (CAS 138071-82-6) Market Size by Application, 2019-2021
5.2.2 By Application, Global Gadobutrol (CAS 138071-82-6) Price, 2020-2021
6 GEOGRAPHIC ANALYSIS
6.1 Introduction
6.2 North America
6.2.1 Macroeconomic Indicators of US
6.2.2 US
6.2.3 Canada
6.3 Europe
6.3.1 Macroeconomic Indicators of Europe
6.3.2 Germany
6.3.3 France
6.3.4 UK
6.3.5 Italy
6.4 Asia-Pacific
6.4.1 Macroeconomic Indicators of Asia-Pacific
6.4.2 China
6.4.3 Japan
6.4.4 South Korea
6.4.5 India
6.4.6 ASEAN
6.5 Rest of World
6.5.1 Latin America
6.5.2 Middle East and Africa
7 COMPANY PROFILES
7.1 Bayer HealthCare Pharmaceuticals Inc.
7.1.1 Bayer HealthCare Pharmaceuticals Inc. Business Overview
7.1.2 Bayer HealthCare Pharmaceuticals Inc. Gadobutrol (CAS 138071-82-6) Quarterly Production and Revenue, 2020
7.1.3 Bayer HealthCare Pharmaceuticals Inc. Gadobutrol (CAS 138071-82-6) Product Introduction
7.1.4 Bayer HealthCare Pharmaceuticals Inc. Response to COVID-19 and Related Developments
7.2 SWAPNROOP DRUGS & PHARMACEUTICALS
7.2.1 SWAPNROOP DRUGS & PHARMACEUTICALS Business Overview
7.2.2 SWAPNROOP DRUGS & PHARMACEUTICALS Gadobutrol (CAS 138071-82-6) Quarterly Production and Revenue, 2020
7.2.3 SWAPNROOP DRUGS & PHARMACEUTICALS Gadobutrol (CAS 138071-82-6) Product Introduction
7.2.4 SWAPNROOP DRUGS & PHARMACEUTICALS Response to COVID-19 and Related Developments
7.3 Manus Aktteva Biopharma LLP
7.3.1 Manus Aktteva Biopharma LLP Business Overview
7.3.2 Manus Aktteva Biopharma LLP Gadobutrol (CAS 138071-82-6) Quarterly Production and Revenue, 2020
7.3.3 Manus Aktteva Biopharma LLP Gadobutrol (CAS 138071-82-6) Product Introduction
7.3.4 Manus Aktteva Biopharma LLP Response to COVID-19 and Related Developments
7.4 Jilin Tely Imp & Exp CO.,LTD
7.4.1 Jilin Tely Imp & Exp CO.,LTD Business Overview
7.4.2 Jilin Tely Imp & Exp CO.,LTD Gadobutrol (CAS 138071-82-6) Quarterly Production and Revenue, 2020
7.4.3 Jilin Tely Imp & Exp CO.,LTD Gadobutrol (CAS 138071-82-6) Product Introduction
7.4.4 Jilin Tely Imp & Exp CO.,LTD Response to COVID-19 and Related Developments
7.5 JinYan Chemicals (ShangHai) Co., Ltd.
7.5.1 JinYan Chemicals (ShangHai) Co., Ltd. Business Overview
7.5.2 JinYan Chemicals (ShangHai) Co., Ltd. Gadobutrol (CAS 138071-82-6) Quarterly Production and Revenue, 2020
7.5.3 JinYan Chemicals (ShangHai) Co., Ltd. Gadobutrol (CAS 138071-82-6) Product Introduction
7.5.4 JinYan Chemicals (ShangHai) Co., Ltd. Response to COVID-19 and Related Developments
7.6 BOC Sciences
7.6.1 BOC Sciences Business Overview
7.6.2 BOC Sciences Gadobutrol (CAS 138071-82-6) Quarterly Production and Revenue, 2020
7.6.3 BOC Sciences Gadobutrol (CAS 138071-82-6) Product Introduction
7.6.4 BOC Sciences Response to COVID-19 and Related Developments
7.7 LGM Pharma
7.7.1 LGM Pharma Business Overview
7.7.2 LGM Pharma Gadobutrol (CAS 138071-82-6) Quarterly Production and Revenue, 2020
7.7.3 LGM Pharma Gadobutrol (CAS 138071-82-6) Product Introduction
7.7.4 LGM Pharma Response to COVID-19 and Related Developments
7.8 Advanced Technology & Industrail Co., Ltd.
7.8.1 Advanced Technology & Industrail Co., Ltd. Business Overview
7.8.2 Advanced Technology & Industrail Co., Ltd. Gadobutrol (CAS 138071-82-6) Quarterly Production and Revenue, 2020
7.8.3 Advanced Technology & Industrail Co., Ltd. Gadobutrol (CAS 138071-82-6) Product Introduction
7.8.4 Advanced Technology & Industrail Co., Ltd. Response to COVID-19 and Related Developments
7.9 MedKoo Biosciences, Inc.
7.9.1 MedKoo Biosciences, Inc. Business Overview
7.9.2 MedKoo Biosciences, Inc. Gadobutrol (CAS 138071-82-6) Quarterly Production and Revenue, 2020
7.9.3 MedKoo Biosciences, Inc. Gadobutrol (CAS 138071-82-6) Product Introduction
7.9.4 MedKoo Biosciences, Inc. Response to COVID-19 and Related Developments
8 SUPPLY CHAIN AND SALES CHANNELS ANALYSIS
8.1 Gadobutrol (CAS 138071-82-6) Supply Chain Analysis
8.1.1 Gadobutrol (CAS 138071-82-6) Supply Chain Analysis
8.1.2 Covid-19 Impact on Gadobutrol (CAS 138071-82-6) Supply Chain
8.2 Distribution Channels Analysis
8.2.1 Gadobutrol (CAS 138071-82-6) Distribution Channels
8.2.2 Covid-19 Impact on Gadobutrol (CAS 138071-82-6) Distribution Channels
8.2.3 Gadobutrol (CAS 138071-82-6) Distributors
8.3 Gadobutrol (CAS 138071-82-6) Customers
9 KEY FINDINGS
10 APPENDIX
10.1 About Us
10.2 Disclaimer
LIST OF TABLES
Table 1. Overview of the World Economic Outlook Projections
Table 2. Summary of World Real per Capita Output (Annual percent change; in international currency at purchasing power parity)
Table 3. European Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 4. Asian and Pacific Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 5. Western Hemisphere Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 6. Middle Eastern and Central Asian Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 7. Covid-19 Impact: Global Major Government Policy
Table 8. The Covid-19 Impact on Gadobutrol (CAS 138071-82-6) Assessment
Table 9. COVID-19 Impact: Gadobutrol (CAS 138071-82-6) Market Trends
Table 10. COVID-19 Impact Global Gadobutrol (CAS 138071-82-6) Market Size
Table 11. Global Gadobutrol (CAS 138071-82-6) Market Size Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (K MT)
Table 12. Global Gadobutrol (CAS 138071-82-6) Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026, (USD/MT)
Table 13. Global Gadobutrol (CAS 138071-82-6) Quarterly Market Size, 2020 (US$ Million) & (K MT)
Table 14. Global Gadobutrol (CAS 138071-82-6) Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (US$ Million)
Table 15. Global Gadobutrol (CAS 138071-82-6) Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (K MT)
Table 16. Global Gadobutrol (CAS 138071-82-6) Market Growth Drivers
Table 17. Global Gadobutrol (CAS 138071-82-6) Market Restraints
Table 18. Global Gadobutrol (CAS 138071-82-6) Market Opportunities
Table 19. Global Gadobutrol (CAS 138071-82-6) Market Challenges
Table 20. Key Manufacturers Gadobutrol (CAS 138071-82-6) Quarterly Revenue, 2019 VS 2020 (US$ Million)
Table 21. Top Manufacturers, Gadobutrol (CAS 138071-82-6) Market Size, 2019 (K MT) & (US$ Million)
Table 22. Gadobutrol (CAS 138071-82-6) Factory Price by Manufacturers 2020 (USD/MT)
Table 23. Location of Key Manufacturers Gadobutrol (CAS 138071-82-6) Manufacturing Plants
Table 24. Key Manufacturers Gadobutrol (CAS 138071-82-6) Market Served
Table 25. Date of Key Manufacturers Enter into Gadobutrol (CAS 138071-82-6) Market
Table 26. Key Manufacturers Gadobutrol (CAS 138071-82-6) Product Type
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Gadobutrol (CAS 138071-82-6) Market Size by Type, 2020, (US$ Million)
Table 29. Global Gadobutrol (CAS 138071-82-6) Market Size by Type, 2020 (K MT)
Table 30. Global Gadobutrol (CAS 138071-82-6) Price: by Type, 2020-2021 (USD/MT)
Table 31. Global Gadobutrol (CAS 138071-82-6) Market Size by Application: 2020-2021 (US$ Million)
Table 32. Global Gadobutrol (CAS 138071-82-6) Market Size by Application, 2020-2021 (K MT)
Table 33. Global Gadobutrol (CAS 138071-82-6) Price: by Application, 2020-2021 (USD/MT)
Table 34. Global Gadobutrol (CAS 138071-82-6) Market Size by Region, 2019-2021 (US$ Million)
Table 35. Global Gadobutrol (CAS 138071-82-6) Market Size by Region, 2019-2021 (K MT)
Table 36. By Country, North America Gadobutrol (CAS 138071-82-6) Market Size, 2019-2021 (US$ Million)
Table 37. By Country, North America Gadobutrol (CAS 138071-82-6) Market Size, 2019-2021 (K MT)
Table 38. US Gadobutrol (CAS 138071-82-6) Market Size, 2019-2021 (US$ Million) & (K MT)
Table 39. Canada Gadobutrol (CAS 138071-82-6) Market Size, 2019-2021 (US$ Million) & (K MT)
Table 40. Macroeconomic Indicators of Europe (Germany, France, UK and Italy)
Table 41. By Country, Europe Gadobutrol (CAS 138071-82-6) Market Size, 2019-2021 (US$ Million)
Table 42. By Country, Europe Gadobutrol (CAS 138071-82-6) Market Size, 2019-2021 (K MT)
Table 43. Germany Gadobutrol (CAS 138071-82-6) Market Size, 2019-2021 (US$ Million) & (K MT)
Table 44. France Gadobutrol (CAS 138071-82-6) Market Size, 2019-2021 (US$ Million) & (K MT)
Table 45. UK Gadobutrol (CAS 138071-82-6) Market Size, 2019-2021 (US$ Million) & (K MT)
Table 46. Italy Gadobutrol (CAS 138071-82-6) Market Size, 2019-2021 (US$ Million) & (K MT)
Table 47. Macroeconomic Indicators of Asia-Pacific (China, Japan, South Korea, India and ASEAN)
Table 48. By Region, Asia-Pacific Gadobutrol (CAS 138071-82-6) Market Size, 2019-2021 (US$ Million)
Table 49. By Region, Asia-Pacific Gadobutrol (CAS 138071-82-6) Market Size, 2019-2021 (K MT)
Table 50. China Gadobutrol (CAS 138071-82-6) Market Size, 2019-2021 (US$ Million) & (K MT)
Table 51. Japan Gadobutrol (CAS 138071-82-6) Market Size, 2019-2021 (US$ Million) & (K MT)
Table 52. South Korea Gadobutrol (CAS 138071-82-6) Market Size, 2019-2021 (US$ Million) & (K MT)
Table 53. India Gadobutrol (CAS 138071-82-6) Market Size, 2019-2021 (US$ Million) & (K MT)
Table 54. ASEAN Gadobutrol (CAS 138071-82-6) Market Size, 2019-2021 (US$ Million) & (K MT)
Table 55. Latin America Gadobutrol (CAS 138071-82-6) Market Size, 2019-2021 (US$ Million) & (K MT)
Table 56. Middle East and Africa Gadobutrol (CAS 138071-82-6) Market Size, 2019-2021 (US$ Million) & (K MT)
Table 57. Bayer HealthCare Pharmaceuticals Inc. Business Overview
Table 58. Bayer HealthCare Pharmaceuticals Inc. Gadobutrol (CAS 138071-82-6) Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 59. Bayer HealthCare Pharmaceuticals Inc. Gadobutrol (CAS 138071-82-6) Product
Table 60. Bayer HealthCare Pharmaceuticals Inc. Response to COVID-19 and Related Developments
Table 61. SWAPNROOP DRUGS & PHARMACEUTICALS Business Overview
Table 62. SWAPNROOP DRUGS & PHARMACEUTICALS Gadobutrol (CAS 138071-82-6) Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 63. SWAPNROOP DRUGS & PHARMACEUTICALS Gadobutrol (CAS 138071-82-6) Product
Table 64. SWAPNROOP DRUGS & PHARMACEUTICALS Response to COVID-19 and Related Developments
Table 65. Manus Aktteva Biopharma LLP Business Overview
Table 66. Manus Aktteva Biopharma LLP Gadobutrol (CAS 138071-82-6) Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 67. Manus Aktteva Biopharma LLP Gadobutrol (CAS 138071-82-6) Product
Table 68. Manus Aktteva Biopharma LLP Response to COVID-19 and Related Developments
Table 69. Jilin Tely Imp & Exp CO.,LTD Business Overview
Table 70. Jilin Tely Imp & Exp CO.,LTD Gadobutrol (CAS 138071-82-6) Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 71. Jilin Tely Imp & Exp CO.,LTD Gadobutrol (CAS 138071-82-6) Product
Table 72. Jilin Tely Imp & Exp CO.,LTD Response to COVID-19 and Related Developments
Table 73. JinYan Chemicals (ShangHai) Co., Ltd. Business Overview
Table 74. JinYan Chemicals (ShangHai) Co., Ltd. Gadobutrol (CAS 138071-82-6) Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 75. JinYan Chemicals (ShangHai) Co., Ltd. Gadobutrol (CAS 138071-82-6) Product
Table 76. JinYan Chemicals (ShangHai) Co., Ltd. Response to COVID-19 and Related Developments
Table 77. BOC Sciences Business Overview
Table 78. BOC Sciences Gadobutrol (CAS 138071-82-6) Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 79. BOC Sciences Gadobutrol (CAS 138071-82-6) Product
Table 80. BOC Sciences Response to COVID-19 and Related Developments
Table 81. LGM Pharma Business Overview
Table 82. LGM Pharma Gadobutrol (CAS 138071-82-6) Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 83. LGM Pharma Gadobutrol (CAS 138071-82-6) Product
Table 84. LGM Pharma Response to COVID-19 and Related Developments
Table 85. Advanced Technology & Industrail Co., Ltd. Business Overview
Table 86. Advanced Technology & Industrail Co., Ltd. Gadobutrol (CAS 138071-82-6) Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 87. Advanced Technology & Industrail Co., Ltd. Gadobutrol (CAS 138071-82-6) Product
Table 88. Advanced Technology & Industrail Co., Ltd. Response to COVID-19 and Related Developments
Table 89. MedKoo Biosciences, Inc. Business Overview
Table 90. MedKoo Biosciences, Inc. Gadobutrol (CAS 138071-82-6) Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 91. MedKoo Biosciences, Inc. Gadobutrol (CAS 138071-82-6) Product
Table 92. MedKoo Biosciences, Inc. Response to COVID-19 and Related Developments
Table 93. Gadobutrol (CAS 138071-82-6) Distributors List
Table 94. Gadobutrol (CAS 138071-82-6) Customers List
Table 95. Covid-19 Impact on Gadobutrol (CAS 138071-82-6) Customers
Table 1. Overview of the World Economic Outlook Projections
Table 2. Summary of World Real per Capita Output (Annual percent change; in international currency at purchasing power parity)
Table 3. European Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 4. Asian and Pacific Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 5. Western Hemisphere Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 6. Middle Eastern and Central Asian Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 7. Covid-19 Impact: Global Major Government Policy
Table 8. The Covid-19 Impact on Gadobutrol (CAS 138071-82-6) Assessment
Table 9. COVID-19 Impact: Gadobutrol (CAS 138071-82-6) Market Trends
Table 10. COVID-19 Impact Global Gadobutrol (CAS 138071-82-6) Market Size
Table 11. Global Gadobutrol (CAS 138071-82-6) Market Size Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (K MT)
Table 12. Global Gadobutrol (CAS 138071-82-6) Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026, (USD/MT)
Table 13. Global Gadobutrol (CAS 138071-82-6) Quarterly Market Size, 2020 (US$ Million) & (K MT)
Table 14. Global Gadobutrol (CAS 138071-82-6) Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (US$ Million)
Table 15. Global Gadobutrol (CAS 138071-82-6) Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (K MT)
Table 16. Global Gadobutrol (CAS 138071-82-6) Market Growth Drivers
Table 17. Global Gadobutrol (CAS 138071-82-6) Market Restraints
Table 18. Global Gadobutrol (CAS 138071-82-6) Market Opportunities
Table 19. Global Gadobutrol (CAS 138071-82-6) Market Challenges
Table 20. Key Manufacturers Gadobutrol (CAS 138071-82-6) Quarterly Revenue, 2019 VS 2020 (US$ Million)
Table 21. Top Manufacturers, Gadobutrol (CAS 138071-82-6) Market Size, 2019 (K MT) & (US$ Million)
Table 22. Gadobutrol (CAS 138071-82-6) Factory Price by Manufacturers 2020 (USD/MT)
Table 23. Location of Key Manufacturers Gadobutrol (CAS 138071-82-6) Manufacturing Plants
Table 24. Key Manufacturers Gadobutrol (CAS 138071-82-6) Market Served
Table 25. Date of Key Manufacturers Enter into Gadobutrol (CAS 138071-82-6) Market
Table 26. Key Manufacturers Gadobutrol (CAS 138071-82-6) Product Type
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Gadobutrol (CAS 138071-82-6) Market Size by Type, 2020, (US$ Million)
Table 29. Global Gadobutrol (CAS 138071-82-6) Market Size by Type, 2020 (K MT)
Table 30. Global Gadobutrol (CAS 138071-82-6) Price: by Type, 2020-2021 (USD/MT)
Table 31. Global Gadobutrol (CAS 138071-82-6) Market Size by Application: 2020-2021 (US$ Million)
Table 32. Global Gadobutrol (CAS 138071-82-6) Market Size by Application, 2020-2021 (K MT)
Table 33. Global Gadobutrol (CAS 138071-82-6) Price: by Application, 2020-2021 (USD/MT)
Table 34. Global Gadobutrol (CAS 138071-82-6) Market Size by Region, 2019-2021 (US$ Million)
Table 35. Global Gadobutrol (CAS 138071-82-6) Market Size by Region, 2019-2021 (K MT)
Table 36. By Country, North America Gadobutrol (CAS 138071-82-6) Market Size, 2019-2021 (US$ Million)
Table 37. By Country, North America Gadobutrol (CAS 138071-82-6) Market Size, 2019-2021 (K MT)
Table 38. US Gadobutrol (CAS 138071-82-6) Market Size, 2019-2021 (US$ Million) & (K MT)
Table 39. Canada Gadobutrol (CAS 138071-82-6) Market Size, 2019-2021 (US$ Million) & (K MT)
Table 40. Macroeconomic Indicators of Europe (Germany, France, UK and Italy)
Table 41. By Country, Europe Gadobutrol (CAS 138071-82-6) Market Size, 2019-2021 (US$ Million)
Table 42. By Country, Europe Gadobutrol (CAS 138071-82-6) Market Size, 2019-2021 (K MT)
Table 43. Germany Gadobutrol (CAS 138071-82-6) Market Size, 2019-2021 (US$ Million) & (K MT)
Table 44. France Gadobutrol (CAS 138071-82-6) Market Size, 2019-2021 (US$ Million) & (K MT)
Table 45. UK Gadobutrol (CAS 138071-82-6) Market Size, 2019-2021 (US$ Million) & (K MT)
Table 46. Italy Gadobutrol (CAS 138071-82-6) Market Size, 2019-2021 (US$ Million) & (K MT)
Table 47. Macroeconomic Indicators of Asia-Pacific (China, Japan, South Korea, India and ASEAN)
Table 48. By Region, Asia-Pacific Gadobutrol (CAS 138071-82-6) Market Size, 2019-2021 (US$ Million)
Table 49. By Region, Asia-Pacific Gadobutrol (CAS 138071-82-6) Market Size, 2019-2021 (K MT)
Table 50. China Gadobutrol (CAS 138071-82-6) Market Size, 2019-2021 (US$ Million) & (K MT)
Table 51. Japan Gadobutrol (CAS 138071-82-6) Market Size, 2019-2021 (US$ Million) & (K MT)
Table 52. South Korea Gadobutrol (CAS 138071-82-6) Market Size, 2019-2021 (US$ Million) & (K MT)
Table 53. India Gadobutrol (CAS 138071-82-6) Market Size, 2019-2021 (US$ Million) & (K MT)
Table 54. ASEAN Gadobutrol (CAS 138071-82-6) Market Size, 2019-2021 (US$ Million) & (K MT)
Table 55. Latin America Gadobutrol (CAS 138071-82-6) Market Size, 2019-2021 (US$ Million) & (K MT)
Table 56. Middle East and Africa Gadobutrol (CAS 138071-82-6) Market Size, 2019-2021 (US$ Million) & (K MT)
Table 57. Bayer HealthCare Pharmaceuticals Inc. Business Overview
Table 58. Bayer HealthCare Pharmaceuticals Inc. Gadobutrol (CAS 138071-82-6) Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 59. Bayer HealthCare Pharmaceuticals Inc. Gadobutrol (CAS 138071-82-6) Product
Table 60. Bayer HealthCare Pharmaceuticals Inc. Response to COVID-19 and Related Developments
Table 61. SWAPNROOP DRUGS & PHARMACEUTICALS Business Overview
Table 62. SWAPNROOP DRUGS & PHARMACEUTICALS Gadobutrol (CAS 138071-82-6) Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 63. SWAPNROOP DRUGS & PHARMACEUTICALS Gadobutrol (CAS 138071-82-6) Product
Table 64. SWAPNROOP DRUGS & PHARMACEUTICALS Response to COVID-19 and Related Developments
Table 65. Manus Aktteva Biopharma LLP Business Overview
Table 66. Manus Aktteva Biopharma LLP Gadobutrol (CAS 138071-82-6) Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 67. Manus Aktteva Biopharma LLP Gadobutrol (CAS 138071-82-6) Product
Table 68. Manus Aktteva Biopharma LLP Response to COVID-19 and Related Developments
Table 69. Jilin Tely Imp & Exp CO.,LTD Business Overview
Table 70. Jilin Tely Imp & Exp CO.,LTD Gadobutrol (CAS 138071-82-6) Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 71. Jilin Tely Imp & Exp CO.,LTD Gadobutrol (CAS 138071-82-6) Product
Table 72. Jilin Tely Imp & Exp CO.,LTD Response to COVID-19 and Related Developments
Table 73. JinYan Chemicals (ShangHai) Co., Ltd. Business Overview
Table 74. JinYan Chemicals (ShangHai) Co., Ltd. Gadobutrol (CAS 138071-82-6) Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 75. JinYan Chemicals (ShangHai) Co., Ltd. Gadobutrol (CAS 138071-82-6) Product
Table 76. JinYan Chemicals (ShangHai) Co., Ltd. Response to COVID-19 and Related Developments
Table 77. BOC Sciences Business Overview
Table 78. BOC Sciences Gadobutrol (CAS 138071-82-6) Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 79. BOC Sciences Gadobutrol (CAS 138071-82-6) Product
Table 80. BOC Sciences Response to COVID-19 and Related Developments
Table 81. LGM Pharma Business Overview
Table 82. LGM Pharma Gadobutrol (CAS 138071-82-6) Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 83. LGM Pharma Gadobutrol (CAS 138071-82-6) Product
Table 84. LGM Pharma Response to COVID-19 and Related Developments
Table 85. Advanced Technology & Industrail Co., Ltd. Business Overview
Table 86. Advanced Technology & Industrail Co., Ltd. Gadobutrol (CAS 138071-82-6) Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 87. Advanced Technology & Industrail Co., Ltd. Gadobutrol (CAS 138071-82-6) Product
Table 88. Advanced Technology & Industrail Co., Ltd. Response to COVID-19 and Related Developments
Table 89. MedKoo Biosciences, Inc. Business Overview
Table 90. MedKoo Biosciences, Inc. Gadobutrol (CAS 138071-82-6) Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 91. MedKoo Biosciences, Inc. Gadobutrol (CAS 138071-82-6) Product
Table 92. MedKoo Biosciences, Inc. Response to COVID-19 and Related Developments
Table 93. Gadobutrol (CAS 138071-82-6) Distributors List
Table 94. Gadobutrol (CAS 138071-82-6) Customers List
Table 95. Covid-19 Impact on Gadobutrol (CAS 138071-82-6) Customers
LIST OF FIGURES
Figure 1. Gadobutrol (CAS 138071-82-6) Product Picture
Figure 2. Gadobutrol (CAS 138071-82-6) Market Segmentation
Figure 3. Research Objectives
Figure 4. Research Process
Figure 5. Data Triangulation
Figure 6. Research Approach
Figure 7. Commodity Prices-Metals Price Indices
Figure 8. Commodity Prices- Precious Metal Price Indices
Figure 9. Commodity Prices- Agricultural Raw Material Price Indices
Figure 10. Commodity Prices- Food and Beverage Price Indices
Figure 11. Commodity Prices- Fertilizer Price Indices
Figure 12. Commodity Prices- Energy Price Indices
Figure 13. G20+: Economic Policy Responses to COVID-19
Figure 14. Global Gadobutrol (CAS 138071-82-6) Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (US$ Million)
Figure 15. Global Gadobutrol (CAS 138071-82-6) Market Size, Pre-COVID-19 and Post- COVID-19, Year-over-Year Growth Rate, 2015-2026 (%)
Figure 16. Global Gadobutrol (CAS 138071-82-6) Market Size, Quarterly Growth, 2020-2021 (%)
Figure 17. Global Gadobutrol (CAS 138071-82-6) Market Size, Market Share by Type, 2019 VS 2020 (%)
Figure 18. Global Gadobutrol (CAS 138071-82-6) Market Size, Market Share by Application, 2019 VS 2020 (%)
Figure 19. Global Gadobutrol (CAS 138071-82-6) Market Size Market Share by Region, 2019 VS 2020 (%)
Figure 20. United States Composite PMI and GDP
Figure 21. Eurozone Composite PMI and GDP
Figure 22. Eurozone Core v. Periphery PMI Output Indices
Figure 23. Core v. Periphery PMI Employment Indices
Figure 24. UK Composite PMI and GDP
Figure 25. Caixin China Composite Output Index
Figure 26. Caixin China General Services Business Activity Index
Figure 27. Japan Composite Output Index
Figure 28. South Korea Manufacturing PMI
Figure 29. India Composite Output Index
Figure 30. ASEAN Manufacturing PMI
Figure 31. By Region, Asia-Pacific Gadobutrol (CAS 138071-82-6) Market Size Market Share, 2019-2021
Figure 1. Gadobutrol (CAS 138071-82-6) Product Picture
Figure 2. Gadobutrol (CAS 138071-82-6) Market Segmentation
Figure 3. Research Objectives
Figure 4. Research Process
Figure 5. Data Triangulation
Figure 6. Research Approach
Figure 7. Commodity Prices-Metals Price Indices
Figure 8. Commodity Prices- Precious Metal Price Indices
Figure 9. Commodity Prices- Agricultural Raw Material Price Indices
Figure 10. Commodity Prices- Food and Beverage Price Indices
Figure 11. Commodity Prices- Fertilizer Price Indices
Figure 12. Commodity Prices- Energy Price Indices
Figure 13. G20+: Economic Policy Responses to COVID-19
Figure 14. Global Gadobutrol (CAS 138071-82-6) Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (US$ Million)
Figure 15. Global Gadobutrol (CAS 138071-82-6) Market Size, Pre-COVID-19 and Post- COVID-19, Year-over-Year Growth Rate, 2015-2026 (%)
Figure 16. Global Gadobutrol (CAS 138071-82-6) Market Size, Quarterly Growth, 2020-2021 (%)
Figure 17. Global Gadobutrol (CAS 138071-82-6) Market Size, Market Share by Type, 2019 VS 2020 (%)
Figure 18. Global Gadobutrol (CAS 138071-82-6) Market Size, Market Share by Application, 2019 VS 2020 (%)
Figure 19. Global Gadobutrol (CAS 138071-82-6) Market Size Market Share by Region, 2019 VS 2020 (%)
Figure 20. United States Composite PMI and GDP
Figure 21. Eurozone Composite PMI and GDP
Figure 22. Eurozone Core v. Periphery PMI Output Indices
Figure 23. Core v. Periphery PMI Employment Indices
Figure 24. UK Composite PMI and GDP
Figure 25. Caixin China Composite Output Index
Figure 26. Caixin China General Services Business Activity Index
Figure 27. Japan Composite Output Index
Figure 28. South Korea Manufacturing PMI
Figure 29. India Composite Output Index
Figure 30. ASEAN Manufacturing PMI
Figure 31. By Region, Asia-Pacific Gadobutrol (CAS 138071-82-6) Market Size Market Share, 2019-2021
